Quality Quotient
Quality Quotient, RiverArk’s flagship newsletter, explores how quality assurance in life sciences is evolving from compliance to strategic capability. Covering regulatory trends, digital transformation, AI governance, and inspection readiness, each edition provides expert insights to help organisations build resilient, high-performing quality systems.
Quality Quotient - 21st Edition
April 2026
Addressing execution gaps and defending digital systems under inspection.
Quality Quotient - 20th Edition
March 2026
SQA 2026 sponsorship and integrating AI into GxP frameworks.
Quality Quotient - 19th Edition
February 2026
Navigating uncertainty in life sciences: the growing role of quality
Quality Quotient – 18th Edition
January 2025
Joint FDA/EMA AI principles and the move toward auditable AI governance.
Quality Quotient – 17th Edition
December 2025
FDA gene therapy approvals and CEO reflections on RiverArk’s expansion.
Quality Quotient – 16th Edition
November 2025
Pharma manufacturing is going digital: a new AI-enabled “digital twin” platform uses real-time process data to create virtual
replicas of production lines, optimising
Quality Quotient - 15th Edition
October 2025
As part of this year’s Innovation
Theatres, RiverArk will deliver a special
session titled “Lean Times, Smart
Quality: QA Adaptation to Budget
Restructuring.”
Quality Quotient - 14th Edition
September 2025
The September edition of The Quality Quotient explores regulatory shifts, industry trends, and AI-driven innovation, helping QA professionals stay ahead in a rapidly evolving life sciences landscape.
Quality Quotient - 13th Edition
August 2025
Multiple FDA decisions this month spotlight both innovation and regulatory intricacies
Quality Quotient - 21st Edition
April 2026
Addressing execution gaps and defending digital systems under inspection.
Quality Quotient - 20th Edition
March 2026
SQA 2026 sponsorship and integrating AI into GxP frameworks.
Quality Quotient - 19th Edition
February 2026
Navigating uncertainty in life sciences: the growing role of quality
Quality Quotient – 18th Edition
January 2025
Joint FDA/EMA AI principles and the move toward auditable AI governance.
Quality Quotient – 17th Edition
December 2025
FDA gene therapy approvals and CEO reflections on RiverArk’s expansion.
Quality Quotient – 16th Edition
November 2025
Pharma manufacturing is going digital: a new AI-enabled “digital twin” platform uses real-time process data to create virtual
replicas of production lines, optimising
Quality Quotient - 15th Edition
October 2025
As part of this year’s Innovation
Theatres, RiverArk will deliver a special
session titled “Lean Times, Smart
Quality: QA Adaptation to Budget
Restructuring.”
Quality Quotient - 14th Edition
September 2025
The September edition of The Quality Quotient explores regulatory shifts, industry trends, and AI-driven innovation, helping QA professionals stay ahead in a rapidly evolving life sciences landscape.
Quality Quotient - 13th Edition
August 2025
Multiple FDA decisions this month spotlight both innovation and regulatory intricacies
